Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan · Delayed Price · Currency is JPY 4,650.00
-40.00 (-0.85%)
Jan 21, 2026, 3:30 PM JST
Kissei Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 17,861 | 15,610 | 14,449 | 13,680 | 16,507 | 7,476 | Upgrade |
Depreciation & Amortization | 4,587 | 4,615 | 4,254 | 4,109 | 3,730 | 3,148 | Upgrade |
Loss (Gain) From Sale of Assets | 2,951 | 3,110 | -80 | -63 | 35 | 10 | Upgrade |
Loss (Gain) From Sale of Investments | -22,096 | -11,999 | -9,119 | -13,133 | -16,161 | -4,727 | Upgrade |
Other Operating Activities | -3,179 | -4,427 | -1,893 | -5,799 | -2,672 | -769 | Upgrade |
Change in Accounts Receivable | -910 | -974 | -5,863 | 27 | 250 | -3,595 | Upgrade |
Change in Inventory | 70 | 1,316 | -3,480 | -3,810 | 1,130 | -6,679 | Upgrade |
Change in Accounts Payable | 2,514 | -291 | 275 | 513 | -3,804 | 2,671 | Upgrade |
Change in Other Net Operating Assets | 9,935 | -439 | -220 | -2,203 | 2,518 | -77 | Upgrade |
Operating Cash Flow | 11,733 | 6,521 | -1,677 | -6,679 | 1,533 | -2,542 | Upgrade |
Operating Cash Flow Growth | 241.97% | - | - | - | - | - | Upgrade |
Capital Expenditures | -5,411 | -4,507 | -1,201 | -2,103 | -1,489 | -931 | Upgrade |
Sale of Property, Plant & Equipment | 506 | 519 | 175 | 78 | 23 | 3 | Upgrade |
Sale (Purchase) of Intangibles | -790 | -523 | -632 | -444 | -430 | -554 | Upgrade |
Investment in Securities | 24,268 | 13,091 | 9,502 | 13,031 | 16,391 | 790 | Upgrade |
Other Investing Activities | -3,616 | -3,627 | 844 | -4,564 | -3,741 | -8,669 | Upgrade |
Investing Cash Flow | 14,955 | 4,952 | 8,690 | 6,001 | 10,776 | -9,329 | Upgrade |
Short-Term Debt Issued | - | 170 | - | - | - | - | Upgrade |
Total Debt Issued | 190 | 170 | - | - | - | - | Upgrade |
Short-Term Debt Repaid | - | -230 | -150 | -150 | -90 | - | Upgrade |
Long-Term Debt Repaid | - | - | - | - | -13 | -16 | Upgrade |
Total Debt Repaid | -180 | -230 | -150 | -150 | -103 | -16 | Upgrade |
Net Debt Issued (Repaid) | 10 | -60 | -150 | -150 | -103 | -16 | Upgrade |
Repurchase of Common Stock | -10,509 | -5,293 | -6,000 | - | - | -1,303 | Upgrade |
Common Dividends Paid | -4,343 | -3,801 | -3,722 | -3,135 | -2,536 | -2,475 | Upgrade |
Other Financing Activities | -186 | -171 | -134 | -135 | -117 | -206 | Upgrade |
Financing Cash Flow | -15,028 | -9,325 | -10,006 | -3,420 | -2,756 | -4,000 | Upgrade |
Foreign Exchange Rate Adjustments | 74 | 27 | -3 | -21 | 4 | - | Upgrade |
Miscellaneous Cash Flow Adjustments | 98 | 96 | -1 | -1 | - | -1 | Upgrade |
Net Cash Flow | 11,832 | 2,271 | -2,997 | -4,120 | 9,557 | -15,872 | Upgrade |
Free Cash Flow | 6,322 | 2,014 | -2,878 | -8,782 | 44 | -3,473 | Upgrade |
Free Cash Flow Growth | 700.25% | - | - | - | - | - | Upgrade |
Free Cash Flow Margin | 6.89% | 2.28% | -3.81% | -13.01% | 0.07% | -5.03% | Upgrade |
Free Cash Flow Per Share | 149.26 | 46.17 | -63.59 | -190.44 | 0.95 | -74.42 | Upgrade |
Cash Interest Paid | 25 | 22 | 18 | 20 | 23 | 23 | Upgrade |
Cash Income Tax Paid | 3,486 | 4,357 | 1,834 | 5,699 | 2,567 | 652 | Upgrade |
Levered Free Cash Flow | 9,579 | 2,448 | 200.38 | -7,654 | 3,843 | -7,691 | Upgrade |
Unlevered Free Cash Flow | 9,595 | 2,461 | 211.63 | -7,641 | 3,858 | -7,677 | Upgrade |
Change in Working Capital | 11,609 | -388 | -9,288 | -5,473 | 94 | -7,680 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.